Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNDiGO study of ND0612 as adjunct to oral levodopa in Parkinson's disease with motor fluctuations
2016-002033-30Phase 3Active
- Sponsor
- NeuroDerm Ltd.
- Start
- Aug 2016
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing ND0612 adjunct treatment arm with Placebo adjunct treatment arm (2 arms). Primary endpoint: Change from baseline to Week 16 in mean percentage of OFF time. Started Aug 2016; status: active.
02
Drugs
ND0612
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2016-002033-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002033-30.